Millennium's Dunsire named as first woman on Takeda board; Medivir collaboration focuses on new drugs to combat antibiotic-resistant bacteria;

 @FierceBiotech: Ultrasound pill could replace daily injections. More | Follow @FierceBiotech

 @JohnCFierce: The cliffhanger: FDA set to decide on Arena's lorcaserin - (I suspect it's yes, but I wouldn't be flabbergasted by delay). Story | Follow @JohnCFierce

 @RyanMFierce: Why mobile tech isn't ideal for recruitment in clinical trials. More | Follow @RyanMFierce

> Millennium Pharmaceuticals CEO Deborah Dunsire has won a board position at Takeda. She's only the third non-Japanese citizen and the first woman to gain a seat on the board of Takeda, which owns Millennium. Report

> Beverly, MA-based Cellceutix has won FDA approval to launch a Phase I study of its experimental cancer drug Kevetrin. Story

> Sweden's Medivir AB has launched a collaboration with researchers at the Swedish University of Agricultural Sciences aimed at identifying and developing new drugs against antibiotic-resistant bacteria. Release

> Shares of Israel's Prolor jumped on positive Phase II data for its weekly growth hormone treatment. Story

Pharma News

 @FiercePharma: S&P gives Novartis props for R&D productivity, cites "good chance" of "at least stable" sales despite Diovan loss. Report | Follow @FiercePharma

> Merck, AstraZeneca rejig stomach-drug partnership. Story

> PDUFA goes to the president. News

> Amylin shareholder sues board for self-enrichment. News

Medical Devices News 

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Top 10 Medical Devices CEO Salaries of 2011. Special Report

> Lab21, mystery pharma partner to launch colon cancer companion Dx in 2012. More

> Infraredx penetrates Japanese mkt with $50M Nipro deal. News

> Ohio devicemaker adding jobs after $5M tax break. Article

Drug Delivery News

 @DamianFierce: With the diabetes market burgeoning around the globe, Fierce takes a look at the top 5 insulin-delivery techs to watch. Special Report | Follow @DamianFierce

> Nanoparticles could help block herpes infection. News

> Cholesterol boosts cancer nanotherapy. Article

> Researchers cook up sugar-based capsules for drug delivery. Item

> West teams with Amgen for injectable delivery. Story

Biomarkers News

> Pregnancy biomarkers linked with long-term cardiovascular risk. Story

> Biomarker might cut unneeded thyroid surgery. Article

> Alzheimer's blood test moves closer. News

> FDA approves Beckman Coulter's prostate blood test. More

And Finally… Lund University investigators have been tracking how Parkinson's disease spreads through the brain in a process in which misfolded proteins travel from sick to healthy cells, much like Mad Cow disease. Release

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.